Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor

被引:38
|
作者
MacKenzie, CJ
Lutz, EM
Johnson, MS
Robertson, DN
Holland, PJ
Mitchell, R
机构
[1] Univ Edinburgh, Dept Biomed Sci, Membrane & Adapter Prot Cooperat Grp, Membrane Biol Grp,MRC, Edinburgh EH8 9XD, Midlothian, Scotland
[2] MRC, Brain Metab Unit, Edinburgh EH8 9JZ, Midlothian, Scotland
关键词
D O I
10.1210/en.142.3.1209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 (VPAC(2)) receptor was shown to induce both [H-3]inositol phosphate ([H-3]InsP) and cAMP production in transfected COS7 cells and in GH(3) cells where it is natively expressed. Neither cholera toxin nor forskolin could elicit an equivalent [H-3]InsP response, suggesting independent coupling of the two pathways. The VPAC(2) receptor-mediated [H-3]InsP response was partially inhibited by pertussis toxin (Ptx) and by the G beta gamma -sequestering C-terminal fragment of GRK2 (GRK2-ct) in COS7 and GH, cells, whereas responses of control receptors were unaffected. Blockers of receptor-activated Ca2+ influx pathways (Co2+ and SKF 96365) also partially inhibited VPAC(2) receptor-mediated [H-3]InsP responses. This inhibition was not present in the component of the response remaining after Ptx treatment. A range of blockers of voltage-sensitive Ca2+ channels were ineffective, consistent with the reported lack of these channels in COS7 cells. The data suggest that the VPAC(2) receptor may couple to phospholipase C through both Ptx-insensitive and Ptx-sensitive G proteins (G(q/11) and C-i/o, respectively) to generate [H-3]InsP. In addition to G beta gamma, G(i/o) activation appears to require receptor-activated Ca2+ entry. This is consistent with the possibility that not only G alpha (q/11)- responsive and G beta gamma -responsive isoforms of phospholipase C but Ca2+-responsive forms may contribute to the overall [H-3]InsP response.
引用
收藏
页码:1209 / 1217
页数:9
相关论文
共 50 条
  • [31] Pituitary adenylate cyclase-activating polypeptide does not colocalize with vasoactive intestinal polypeptide in the hypothalamic magnocellular nuclei and posterior pituitary of cats and rats
    Viktoria Vereczki
    Katalin Köves
    Zsuzsanna E. Tóth
    Akemichi Baba
    Hitoshi Hashimoto
    Kristóf Fógel
    Akira Arimura
    Mária Kausz
    Endocrine, 2003, 22 : 225 - 237
  • [32] Pituitary adenylate cyclase-activating polypeptide does not colocalize with vasoactive intestinal polypeptide in the hypothalamic magnocellular nuclei and posterior pituitary of cats and rats
    Vereczki, V
    Köves, K
    Tóth, ZE
    Baba, A
    Hashimoto, H
    Fógel, K
    Arimura, A
    Kausz, M
    ENDOCRINE, 2003, 22 (03) : 225 - 237
  • [33] Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity
    Onoue, S
    Endo, K
    Yajima, T
    Kashimoto, K
    REGULATORY PEPTIDES, 2002, 107 (1-3) : 43 - 47
  • [34] On the existence of possible pituitary adenylate cyclase-activating polypeptide adenylate type 1 receptor in earthworms
    Molnar, L.
    Pollak, E.
    Somogyi, I.
    Engelmann, P.
    ISJ-INVERTEBRATE SURVIVAL JOURNAL, 2015, 12 : 173 - 175
  • [35] Estrogens impair hypophagia and hypothalamic cell activation induced by vasoactive intestinal peptide, but not by pituitary adenylate cyclase-activating polypeptide
    Garnica-Siqueira, Marcela Cristina
    Martins, Andressa Busetti
    Monteiro, Erica Cristina Alves Munhoz
    de Oliveira, Maria Heloisa Bernardes
    Baratto, Carolina dos Reis
    Tsutsui, Fabiano Takeo Komay
    de Oliveira, Lucas Leonardo Franca
    Stopa, Larissa Rugila dos Santos
    de Souza, Camila Franciele
    Wunderlich, Ana Luiza Machado
    Zaia, Dimas Augusto Morozin
    Leite, Cristiane Mota
    Zaia, Cassia Thais Bussamra Vieira
    Uchoa, Ernane Torres
    PEPTIDES, 2025, 183
  • [36] The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation
    Freson, K
    Hashimoto, H
    Thys, C
    Wittevrongel, C
    Danloy, S
    Morita, Y
    Shintani, N
    Tomiyama, Y
    Vermylen, J
    Hoylaerts, MF
    Baba, A
    Van Geet, C
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06): : 905 - 912
  • [37] Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on food intake and locomotor activity in the goldfish, Carassius auratus
    Matsuda, Kouhei
    Maruyama, Keisuke
    Nakamachi, Tomoya
    Miura, Tohru
    Shioda, Seiji
    VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY, 2006, 1070 : 417 - 421
  • [38] Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland
    Simonneaux, V
    Kienlen-Campard, P
    Loeffler, JP
    Basille, M
    Gonzalez, BJ
    Vaudry, H
    Robberecht, P
    Pevet, P
    NEUROSCIENCE, 1998, 85 (03) : 887 - 896
  • [39] Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex
    Jolanta B. Zawilska
    Pawel Niewiadomski
    Jerzy Z. Nowak
    Journal of Molecular Neuroscience, 2003, 20 : 153 - 161
  • [40] Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex
    Zawilska, JB
    Niewiadomski, P
    Nowak, JZ
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 20 (02) : 153 - 161